Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of mycobacterium tuberculosis

Scandinavian Journal of Immunology

Volumn 69, Issue 3, 2009, Pages 213-222

  Mustafa, A S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL ANTIGEN; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; HLA DR ANTIGEN; MPB70; MPT63; MT24; MYCOBACTERIUM ANTIGEN; PPE68; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CELL HETEROGENEITY; CELL PROLIFERATION; DONOR; HLA SYSTEM; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; MOLECULE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SEROLOGY; TH1 CELL; TUBERCULOSIS;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CYTOPROTECTION; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE FRAGMENTS; SUBSTRATE SPECIFICITY; TH1 CELLS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 60349097841     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02221.x     Document Type: Article

References (52)

1. Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006 100 : 415 31.
2. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006 367 : 1173 80.
3. Enarson DA. Use of the tuberculin skin test in children. Paediatr Respir Rev 2004 5 (Suppl. A S135 7.
4. Hesseling AC, Marais BJ, Gie RP et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007 25 : 14 8.
5. Lönnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008 29 : 481 91.
6. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 1997 45 : 115 31.
7. Mustafa AS. Progress towards the development of new anti-tuberculosis vaccines. In : Smith Lucy T, ed. Focus on Tuberculosis Research. New York : Nova Science Publishers, Inc, 2005 : 47 76.
8. Wiker HG, Mustafa T, Malen H, Riise AMD. Vaccine approaches to prevent tuberculosis. Scand J Immunol 2006 64 : 243 50.
9. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991 59 : 372 82.
10. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994 62 : 2536 44.
11. Malen H, Berven FS, Fladmark KE, Wiker HG. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007 7 : 1702 18.
12. Manca G, Lyashchenko K, Wiker HG, Usai D, Colangeli R, Gennaro ML. Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun 1997 65 : 16 23.
13. Kawajiri K. Isolation of MPB63 in the culture fluid of Mycobacterium bovis BCG Tokyo: genetical and immunological characterization. Kekkaku 2003 78 : 69 78.
14. Wang BL, XU Y, Li ZM, Xu YM, Weng XH, Wang HH. Antibody response to four secretory proteins from Mycobacterium tuberculosis and their complex antigen in TB patients. Int J Tuberc Lung Dis 2005 9 : 1327 34.
15. Lyashchenko KP, Pollock JM, Colangeli R, Gennaro ML. Diversity of antigen recognition by serum antibodies in experimental bovine tuberculosis. Infect Immun 1998 66 : 5344 9.
16. Pan Y, Cai H, Li SX, Tian X, Li T, Zhu YX. Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003 35 : 71 6.
17. Mustafa AS. Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 2002 39 : 113 9.
18. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003 38 : 249 56.
19. Al-Attiyah R, El-Shazly A, Mustafa AS. Assessment of in vitro immunity to Mycobacterium tuberculosis in a human peripheral blood infection model using a luciferase reporter construct of M. tuberculosis H37Rv. Clin Exp Immunol 2006 145 : 520 7.
20. Singh H, Raghava GPS. ProPred: Prediction of HLA-DR binding sites. Bioinformatics 2001 17 : 1236 7.
21. Hanif SNM, El-Shamy AM, Al-Attiyah R, Mustafa AS. Whole blood assays to identify Th1 cell antigens and peptides encoded by Mycobacterium tuberculosis-specific RD1 genes. Med Princ Pract 2008 17 : 244 9.
22. Mustafa AS, El-Shamy AM, Madi NM, Amoudy HA, Al-Attiyah R. Cell-mediated immune responses to complex and single mycobacterial antigens in tuberculosis patients with diabetes. Med Princ Pract 2008 17 : 325 30.
23. Al-Attiyah R, Shaban FA, Wiker HG, Oftung F, Mustafa AS. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun 2003 71 : 1953 60.
24. Al-Attiyah R, Mustafa AS. Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1 cell peptides in a novel 24-kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis. Scand J Immunol 2004 59 : 16 24.
25. Mustafa AS, Al-Attiyah R, Hanif SNM, Shaban FA. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin Vaccine Immunol 2008 15 : 916 24.
26. Mustafa AS, Cockle PJ, Shaban F, Hewinson HM, Vordermeier HM. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin Exp Immunol 2002 130 : 37 42.
27. Mustafa AS, Shaban FA. Propred analysis and experimental evaluation of promiscuous Th1 cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2006 86 : 115 24.
28. Mustafa AS, Shaban FA, Abal AT et al. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4+ cell lines. Infect Immun 2000 68 : 3933 40.
29. Al-Attiyah R, Mustafa AS, Abal AT, El-Shamy AM, Dalemans W, Skeiky YAW. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol 2004 138 : 139 44.
30. Al-Attiyah R, Mustafa AS. Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun 2008 76 : 4190 8.
31. Mustafa AS, Oftung F, Amoudy HA et al. Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines. Clin Infect Dis 2000 30 (Suppl. 3 S201 5.
32. Mustafa AS, Amoudy HA, Wiker HG et al. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 1998 48 : 535 43.
33. Al-Attiyah R, Madi N, El-Shamy AS, Wiker H, Andersen P, Mustafa AS. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 2006 47 : 254 61.
34. Mustafa AS, Shaban FA, Al-Attiyah R et al. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 2003 57 : 125 34.
35. Mustafa AS, Abal AT, Shaban F, El-Shamy AM, Amoudy HA. HLA-DR binding prediction and experimental evaluation of mycolyltransferase (Ag85B), a major secreted antigen of Mycobacterium tuberculosis. Med Princ Pract 2005 14 : 140 6.
36. Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005 12 : 491 6.
37. Mustafa AS. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr Pharm Biotechnol 2001 2 : 157 73.
38. Demissie A, Abebe M, Aseffa A et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2. J Immunol 2004 172 : 6938 43.
39. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 2004 84 : 93 101.
40. Mustafa AS. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance. Tuberculosis (Edinb) 2005 85 : 367 76.
41. Mustafa AS. Mycobacterial gene cloning and expression, comparative genomics, bioinformatics and proteomics in relation to the development of new vaccines and diagnostic reagents. Med Princ Pract 2005 14 (Suppl. 1 27 34.
42. Ahmad S, Amoudy HA, Thole JE, Young DB, Mustafa AS. Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene. Scand J Immunol 1999 49 : 515 22.
43. Ahmad S, El-Shazly S, Mustafa AS, Al-Attiyah R. Mammalian cell-entry proteins encoded by the mce3 operon of Mycobacterium tuberculosis are expressed during natural infection in humans. Scand J Immunol 2004 60 : 382 91.
44. Amoudy HA, Ahmad S, Thole JE, Mustafa AS. Demonstration of in vivo expression of a hypothetical open reading frame (ORF-14) encoded by the RD1 region of Mycobacterium tuberculosis. Scand J Immunol 2007 66 : 422 5.
45. Mustafa AS, Skeiky YA, Al-Attiyah R, Alderson MR, Hewinson RG, Vordermeier HM. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Infect Immun 2006 74 : 4566 72.
46. Mustafa AS. HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. Hum Immunol 2000 61 : 166 71.
47. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996 64 : 16 22.
48. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996 178 : 1274 82.
49. Amoudy HA, Al-Turab MB, Mustafa AS. Identification of transcriptionally active open reading frames within the RD1 genomic segment of Mycobacterium tuberculosis. Med Princ Pract 2006 15 : 137 44.
50. Okkels LM, Brock I, Follmann F et al. PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun 2003 71 : 6116 23.
51. Mustafa AS, Lundin KEA, Meloen RH, Shinnick TM, Oftung F. Identification of promiscuous epitopes from the mycobacterial 65 kDa heat shock protein (HSP65) recognized by human CD4+ cells of' the Mycobacterium leprae memory repertoire. Infect Immun 1999 67 : 5683 9.
52. Mustafa AS, Lundin KEA, Meloen RH, Oftung F. Crossreactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein. Clin Exp Immunol 2000 120 : 85 92.